NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
12.13
-0.21 (-1.70%)
At close: Nov 26, 2025, 4:00 PM EST
12.15
+0.02 (0.16%)
After-hours: Nov 26, 2025, 6:55 PM EST
NeoGenomics Employees
NeoGenomics had 2,200 employees as of December 31, 2024. The number of employees increased by 100 or 4.76% compared to the previous year.
Employees
2,200
Change (1Y)
100
Growth (1Y)
4.76%
Revenue / Employee
$322,346
Profits / Employee
-$51,576
Market Cap
1.57B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,200 | 100 | 4.76% |
| Dec 31, 2023 | 2,100 | 0 | - |
| Dec 31, 2022 | 2,100 | 100 | 5.00% |
| Dec 31, 2021 | 2,000 | 300 | 17.65% |
| Dec 31, 2020 | 1,700 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NEO News
- 12 days ago - Neo Performance Materials Inc. (NEO:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - NeoGenomics to Participate in Upcoming Investor Conferences - Business Wire
- 27 days ago - NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors - Business Wire
- 4 weeks ago - NeoGenomics, Inc. (NEO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - NeoGenomics Reports Third Quarter 2025 Results - Business Wire
- 6 weeks ago - NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 - Business Wire
- 7 weeks ago - NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025 - Business Wire
- 2 months ago - NeoGenomics Stock In A Range-Bound Matrix, Weakness Likely Until 2026 - Benzinga